Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase

Figure 3 Comparison of telomerase activity in HepG2 and SMMC-7721 cells treated with cantide. 48 h after treatment with cantide, cells extract was tested for telomerase activity by TRAP-ELISA assay. The results were expressed as means ± SD from three independent experiments. ^aP < 0.05 vs the cells treated with lipofectin alone, ^bP < 0.01 vs the cells treated with lipofectin alone.